Publicado 27/09/2017 10:04
- Comunicado -

Bavencio (avelumab) Approved for Merkel Cell Carcinoma in Japan (3)

Contacts Merck Media Friederike Segeberg +49-6151-72-6328 Investor Relations +49-6151-72-3321 Pfizer Media (US) Sally Beatty +1-212-733-6566 Media (JP) Trupti Deepak Wagh +65-91873247 Investor Relations Ryan Crowe +1-212-733-8160

Photo: http://mma.prnewswire.com/media/477506/M...

Contenido patrocinado